Last week, the European Union imposed its seventh round of sanctions on Russia, imposing a range of new restrictive measures. The new sanctions include a ban on dealings in Russian-origin gold, updates to existing sanctions to bolster the effectiveness
Latest from Kelley Drye & Warren LLP - Page 2
EPA Expands List of PFAS Subject to Toxic Release Inventory Reporting
Earlier this week, on July 18, 2022, U.S. EPA issued a final rule that subjects five new per- and polyfluoroalkyl substances (“PFAS”) to the Toxics Release Inventory (“TRI”) reporting requirements under Section 313 of the Emergency Planning and Community Right-to-Know
Man Sues Bass Pro Over Lifetime Guarantee on Socks
As heat waves spread across the country, many men are looking for opportunities to go without socks. (To those men, I might suggest a good pair of no-show socks but, like with other grooming tips, that’s beyond the scope
NAD Advises Better Disclosures for #1 Claim
Twilio advertises that its customer data platform is the “#1 CDP” and discloses that the claim is based on 2020 market share, as measured by the International Data Corporation. Adobe challenged the claim, arguing, in part, that the 2020 IDC
Upcoming Price Gouging and Employee/HR Data Privacy Webinars
How To Protect Employee/HR Data and Comply with Data Privacy Laws
Wednesday, July 20
As workforces become increasingly mobile and remote work is more the norm, employers face the challenge of balancing the protection of their employees’ personal data and
CBD and Hemp Legal and Regulatory Roundup – July 15, 2022
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
Physicians remain reluctant to prescribe CBD for epilepsy
While the FDA has approved cannabis-derived prescription drug, Epidiolex, for three rare seizure disorders, not much has changed
CARU’s First Decision on “Gender-Restrictive” Ads Also Addresses Jurisdictional Issues
Impact of Dobbs Decision on Employee Benefits
On June 24, 2022, the U.S. Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, overturning Roe v. Wade and holding that there is no constitutionally protected right to abortion. While the Dobbs decision does not make abortion illegal, it does permit
Preparing for Expanded Consumer Rights Requests Under the CPRA
With the clock now running on the comment period for the California Privacy Protection Agency’s (CPPA) Draft Regulations to implement the CPRA – comments are due on August 23 – one of the items on many businesses’ CPRA preparation to-do
Mid-Year Check-in on NAD Food, Supplement and Personal Care Product Cases
The halfway point of 2022 finds NAD digging deep on supplement substantiation and looking closely at whether product names convey misleading claims. Here are highlights from the past quarter and links to our posts from earlier this year. Enjoy!
The